NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Intermetatarsal Bursitis in Patients With Rheumatoid Arthritis

TerminatedNA

Sponsor: Rigshospitalet, Denmark

Conditions: Intermetatarsal Bursitis, Rheumatoid Arthritis

Interventions: Magnetic resonance imaging, Ultrasound, Corticosteroid injection, Clinical foot evaluation, Picture of the feet

Countries: Denmark

The aim of the study is to investigate the incidence and clinical implications of intermetatarsal bursitis (IMB) in patients with rheumatoid arthritis (RA). The hypothesis is that IMB is a cause of pain in patients with RA.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Age \> 18 years
* Forefoot pain and diagnosed with RA (patient group)
* Diagnosed with an axial arthritis (control group)

Exclusion Criteria:

* Age \<18 years
* Open wounds or ongoing infection in the forefoot at the time of examination
* Persons with a history of significant trauma in the forefoot, e.g. any fracture or previous surgeries in the forefoot
* Persons who have previously received intermetatarsal treatment (Morton's neuroma or IMB) in the same foot, e.g. injection within 6 months or operation at any time
* Exclusion from MRI scan only:
* Persons with contraindications to participate in MRI scan
* Persons with severely impaired renal function (GFR \<30 ml/min)

Locations (1)

Glostrup Municipality, Denmark